Ajeganova S, Svensson B, Hafström I; BARFOT Study Group. Low-dose prednisolone treatment of early rheumatoid arthritis and late cardiovascular outcome and survival: 10-year follow-up of a 2-year randomized trial. BMJ Open. 2014 Apr 7; 4(4):e004259.
Arkema EV, Feltelius N, et al.; on behalf of the ARTIS study group. No association between rheumatoid arthritis, amyotrophic lateral sclerosis, and tumour necrosis factor inhibitor treatment. Ann Rheum Dis. 2014 Aug 5.
Arkema EV, Jonsson J, Baecklund E, et al; on behalf of the ARTIS Study Group. Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments? Ann Rheum Dis. 2014 Mar 7.
Bengtsson C, Padyukov L, Källberg H, et al. Thyroxin substitution and the risk of developing rheumatoid arthritis; results from the Swedish population-based EIRA study. Ann Rheum Dis. 2014 Jun; 73(6):1096-100.
Demmelmaier I, Lindkvist A, Nordgren B, et al. ”A gift from heaven” or ”This was not for me”. A mixed methods approach to describe experiences of participation in an outsourced physical activity program for persons with rheumatoid arthritis. Clin Rheumatol. 2014 Jun 20.
Eriksson JK, Karlsson JA, Bratt J, et al. Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial. Ann Rheum Dis. 2014 Apr 15.
Eriksson JK, Askling J, Arkema EV. The Swedish Rheumatology Quality Register: optimization of rheumatic disease assessments using register-enriched data. Clin Exp Rheumatol. 2014 Nov-Dec; 32 Suppl 85(5):147-149.
Frisell T, Hellgren K, Alfredsson L, et al. Familial aggregation of arthritis-related diseases in seropositive and seronegative rheumatoid arthritis: a register-based case-control study in Sweden. Ann Rheum Dis. 2014 Dec 12.
Hafström I, Engvall IL, Rönnelid J, et al. the BARFOT study group. Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: a randomised study. BMJ Open. 2014 Jul 30; 4(7):e005246
Hallert E, Husberg M, Kalkan A, et al. Changes in sociodemographic characteristics at baseline in two Swedish cohorts of patients with early rheumatoid arthritis diagnosed 1996-98 and 2006-09. Scand J Rheumatol. 2014 Oct 29:1-6.
Hallert E, Husberg M, Kalkan A, et al. Early rheumatoid arthritis 6 years after diagnosis is still associated with high direct costs and increasing loss of productivity: the Swedish TIRA project. Scand J Rheumatol. 2014; 43(3):177-83.
Hambardzumyan K, Bolce R, Saevarsdottir S, et al. RF pretreatment multi-biomarker disease activity score and radiographic progression in early RA: results from the SWEFOT trial. Ann Rheum Dis. 2014 May 8.
Han B, Diogo D, Eyre S,et al. Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity. Am J Hum Genet. 2014 Apr 3; 94(4):522-32.
Hellgren K, Smedby KE, Backlin C, et al. Ankylosing spondylitis, psoriatic arthritis, and risk of malignant lymphoma: a cohort study based on nationwide prospectively recorded data from Sweden. Arthritis Rheumatol. 2014 May; 66(5):1282-90.
Jiang X, Trouw LA, van Wesemael TJ, et al. Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies. Ann Rheum Dis. 2014 Oct; 73(10):1761-8.
Jiang X, Alfredsson L, Klareskog L, et al. Smokeless tobacco (moist snuff) use and the risk of developing rheumatoid arthritis: Results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis (EIRA) case-control study. Arthritis Care Res (Hoboken). 2014 Apr 9.
Ljung L, Askling J, Rantapää-Dahlqvist S, et al. The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study. Arthritis Res Ther. 2014 Jun 18; 16(3):R127.
Kastbom A, Forslind K, Ernestam S, et al. Changes in the anticitrullinated peptide antibody response in relation to therapeutic outcome in early rheumatoid arthritis: results from the SWEFOT trial. Ann Rheum Dis. 2014 Dec 30.
Kearsley-Fleet L, Závada J, Hetland ML,et al.; on behalf of the EULAR Study Group for Registers and Observational Drug Studies. The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers. Rheumatology (Oxford). 2014 Nov 27.
Kristensen LE, Bliddal H, Christensen R, et al. Is swollen to tender joint count ratio a new and useful clinical marker for biologic drug response in rheumatoid arthritis? Results from a Swedish cohort. Arthritis Care Res (Hoboken). 2014 Feb; 66(2):173-9.
Nordgren B, Fridén C, Demmelmaier I, et al. Who makes it to the base? Selection procedure for a physical activity trial targeting people with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2014 May; 66(5):662-70.
Nordgren B, Fridén C, Jansson E, et al. Criterion validation of two submaximal aerobic fitness tests, the self-monitoring Fox-walk test and the Åstrand cycle test in people with rheumatoid arthritis. BMC Musculoskelet Disord. 2014 Sep 17; 15:305.
Nordgren B, Fridén C, Demmelmaier I, et al.; the PARA Study Group. An outsourced health-enhancing physical activity programme for people with rheumatoid arthritis: exploration of adherence and response. Rheumatology (Oxford). 2014 Nov 27.
Orellana C, Wedrén S, Källberg H, et al; EIRA Study Group. Parity and the risk of developing rheumatoid arthritis: results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis study. Ann Rheum Dis. 2014 Apr; 73(4):752-5.
Ostlund G, Björk M, Thyberg I, et al. Emotions related to participation restrictions as experienced by patients with early rheumatoid arthritis: a qualitative interview study (the Swedish TIRA project). Clin Rheumatol. 2014 May 17.
Raaschou P, Frisell T, Askling J; for the ARTIS Study Group. TNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid arthritis: a nationwide cohort study. Ann Rheum Dis. 2014 Aug 8.
Ruge T, Södergren A, Wållberg-Jonsson S et al. Circulating plasma levels of cathepsin S and L are not associated with disease severity in patients with rheumatoid arthritis. Scand J Rheumatol. 2014; 43(5):371-3.
Saevarsdottir S, Rezaei H, Geborek P, et al.; for the SWEFOT study group. Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial. Ann Rheum Dis. 2014 Apr 4.
Theander E, Husmark T, Alenius GM,et al. Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA). Ann Rheum Dis. 2014 Feb; 73(2):407-13.
Wadström H, Eriksson J, Neovius M, et al., On Behalf Of The ARTIS Study Group.How good is the coverage and how accurate are exposure data in the Swedish Biologics Register (ARTIS)? Scand J Rheumatol. 2014 Nov 7:1-7.
Wagner CA, Sokolove J, Lahey LJ, et al. Identification of anticitrullinated protein antibody reactivities in a subset of anti-CCP-negative rheumatoid arthritis: association with cigarette smoking and HLA-DRB1 ‘shared epitope’ alleles. Ann Rheum Dis. 2014 Jan 16.